Mesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathways

Bone marrow-derived mesenchymal stem cells (MSCs) have been identified as one possible strategy for the treatment of chronic obstructive pulmonary disease (COPD). Our previous studies have demonstrated that MSC administration has therapeutic potential in airway inflammation and emphysema via a parac...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Wen, Song, Lin, Li, Xiao-Ming, Wang, Di, Guo, Xue-Jun, Xu, Wei-Guo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348625/
https://www.ncbi.nlm.nih.gov/pubmed/25736434
http://dx.doi.org/10.1038/srep08733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348625/
https://www.ncbi.nlm.nih.gov/pubmed/25736434
http://dx.doi.org/10.1038/srep08733

Ejemplares similares